Medical Disclaimer: All records on this platform are unverified, self-reported patient experiences compiled for informational purposes only — not clinical trials or medical advice. Always consult a qualified physician before starting, changing, or discontinuing any medication or procedure. Read full disclaimer

Ambroxol for Hyperacusis & Noxacusis

medication

A secretolytic agent being researched for its potential sodium channel blocking properties.

Read Clinical Overview, Mechanism & Safety Notes

Using Ambroxol for the treatment of hyperacusis represents an "off-label" use of a medication traditionally known as a mucolytic (cough medicine).

While it was originally designed to thin mucus in the respiratory tract, recent research suggests it may play a protective role in the auditory system.

Mechanism of Action: The rationale behind using Ambroxol for hyperacusis lies in its ability to modulate specific ion channels in the inner ear.

  • Sodium Channel Blockade: Ambroxol acts as a potent inhibitor of voltage-gated sodium channels (particularly the Nav1.8 subtype). These channels are involved in the transmission of pain and sensory signals.
  • Glutamate Regulation: It may help regulate the release of glutamate, the primary excitatory neurotransmitter in the auditory pathway. In hyperacusis, "excitotoxicity" (excessive glutamate activity) is thought to cause the auditory nerves to over-fire.
  • Anti-inflammatory & Antioxidant Effects: Ambroxol reduces oxidative stress and inflammation within the cochlea, which can help stabilize the neural pathways that have become hypersensitive due to acoustic trauma or metabolic stress.

It's important to recognize that Ambroxol is a medication with potential risks and side effects. Be sure to thoroughly research it and consult with healthcare professionals before considering its use.

Ambroxol — Patient Outcome Breakdown

Hover over segments or bars to inspect exact case counts and percentages

n = 12 reports
25%≥50% Improved
Any relief: 58.3%•Adverse/Stopped: 8.3%
Significant (75-100%)
1 (8.3%)
Moderate (50-75%)
2 (16.7%)
Mild (<50%)
4 (33.3%)
No Change / Very Mild
4 (33.3%)
Ongoing / Evaluating
0 (0%)
Discontinued (Side FX)
1 (8.3%)
Worsened
0 (0%)

Outcomes by Hyperacusis Subtype

Comparing reported efficacy in Pain (Noxacusis) vs. Loudness cases

Pain / Noxacusis12 cases
Moderate to Significant (≥50%)25%
Any Improvement (Mild + Mod + Sig)58.3%
Loudness Hyperacusis5 cases
Moderate to Significant (≥50%)20%
Any Improvement (Mild + Mod + Sig)80%
12
With Pain H
5
With Loudness
0
Still Ongoing
Showing 12 of 12 reports
Lucky7#12
Pain / NoxacusisLoudness H
No Change / Very Mild
Dose: Takes 150-300mg two sometimes three times a day with meals.months

Seems to help in a very minor way with burning pain and make the pain go away faster Stopped taking due to lack of efficacy and reflux

Source: Discord
Full Report →
Parzival#11
Pain / Noxacusis
No Change / Very Mild
Dose: 90 mg a dayOne month

No change

Source: Discord
Full Report →
Moonlight Dragoness#10
Pain / Noxacusis
Significant (75-100%)

80% decrease in facial pain; even more in facial tingling

Source: Discord
Full Report →
Lazaar#9
Pain / Noxacusis
Mild (<50%)
Dose: Varied between 30 and 120 mg a dayTook it when needed

Decrease in pain and increase in tolerance

Source: Discord
Full Report →
Tofu_steak#8
Pain / Noxacusis
Discontinued (Side FX)
Dose: Doesn't rememberabout 3 weeks

No change (quit due to side effects)

Source: Discord
Full Report →
Olly132#7
Pain / Noxacusis
No Change / Very Mild
Dose: 90 mg 3/daySeveral months

Did not seem to do anything

Source: Discord
Full Report →
Chapuki#6
Pain / Noxacusis
No Change / Very Mild
Onset: 2021Dose: 150 mg/day3-4 weeks

Minor improvement in tolerance, more likely due to time

Source: Discord
Full Report →
Brody#5
Pain / Noxacusis
Moderate (50-75%)
Onset: 2022Dose: Between 30mg-180mg a day when needed9 months

Significant improvement of his pain, no effect on tolerance. Significant reduction in pain about 30 minutes after taking dose and lasts 5-8 hours.

Source: Discord
Full Report →
Carolinian#4
Pain / NoxacusisLoudness H
Moderate (50-75%)
Dose: between 30mg TID to 90mg TIDAt least 6 months

Dramatic improvement in facial pain but no improvement in loudness or tolerance (it may eventually been part of what helped improve tolerance because her pain was bad enough she facial grimaced, which prob kept her in more middle ear engagement)

Source: Discord
Full Report →
Ariel#3
Pain / NoxacusisLoudness H
Mild (<50%)
Dose: 30-90mgAlmost one month

I've been taking Ambroxol every day for almost a month now. My experience has been that it's like a Tylenol for nox. It reduces the pain for a few hours which is helpful if you need to leave the house. However, no long term changes in tolerance, etc.

Source: Discord
Full Report →
Annie#2
Pain / NoxacusisLoudness H
Mild (<50%)
Onset: December 2023Dose: Between 150-180mg daily8 months

Improvement in burning pain after taking 150 mg or more. Also seems to calm down reactive tinnitus flares a bit.

Source: Discord
Full Report →
Marquer#1
Pain / NoxacusisLoudness H
Mild (<50%)
Onset: July 2022Dose: 180 mg daily and 300+ mg during major flares2 years

Improvement in burning pain that lasts between 4 and 6 hours

Source: Discord
Full Report →